Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant

McGill University

$286,875.00

Development of 14-3-3 protein/protein interaction agonists as potential therapies for spinal cord injury and stroke

FY 2019-20

Summary
14-3-3 Adaptor proteins are species which act as molecular chaperones for other proteins in cells. They bind to proteins and this affects the function of the target protein. Fusicoccin A is a naturally occurring molecule which facilitates the binding of 14-3-3 proteins to other proteins in the cell. Research in the Fournier lab at McGill has shown that Fusicoccin A stimulates nerve regrowth by promoting the association of 14-3-3 with another protein called GCN1. In this Project Grant, we will attempt to develop molecules with improved properties as a potential treatment for damage to neural tissue from stroke and spinal cord injury. This will include studying the interaction between 14-3-3 and GCN1 as well as developing and implementing new computer modeling programs to predict new molecules that have desirable properties. We will use these predictions to guide the synthesis and assessment of new potential therapeutic agents.
Program
Project Grant
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
409940
Name
Gleason James L
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Pharmaceutical Sciences
Projecttitle
Development of 14-3-3 protein/protein interaction agonists as potential therapies for spinal cord injury and stroke
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$286,875
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
14-3-3 Protein; Fusiccocin A; Gcn1; Protein/Protein Interaction; Virtual Screening
Abstract
14-3-3 Adaptor proteins are species which act as molecular chaperones for other proteins in cells. They bind to proteins and this affects the function of the target protein. Fusicoccin A is a naturally occurring molecule which facilitates the binding of 14-3-3 proteins to other proteins in the cell. Research in the Fournier lab at McGill has shown that Fusicoccin A stimulates nerve regrowth by promoting the association of 14-3-3 with another protein called GCN1. In this Project Grant, we will attempt to develop molecules with improved properties as a potential treatment for damage to neural tissue from stroke and spinal cord injury. This will include studying the interaction between 14-3-3 and GCN1 as well as developing and implementing new computer modeling programs to predict new molecules that have desirable properties. We will use these predictions to guide the synthesis and assessment of new potential therapeutic agents.
Competitiondate
201909
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Gleason, James L; Fournier, Alyson Elise; Mittermaier, Anthony; Moitessier, Nicolas R
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $286,875~ $0~
McGill University - $286,875 Grant (2019-20) | Canada Spends